Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Opthea.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX health stocks: Rhinomed rockets 80% after securing first government purchase for COVID-19 Rhinoswabs
Health & Biotech
ASX health stocks: EMV’s brain scanner is completed and ready for testing, stock price jumps 16pc
Health & Biotech
ScoPo’s Powerplays: Quarterlies to dictate price moves, as Nanosonics and Neuren come into play
Health & Biotech
The clinical ambitions of these two ASX biotechs just got a boost from the FDA
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
These ASX biotechs are on the verge of releasing Phase III clinical trial results
Health & Biotech
Budget review: Here’s what ASX biotech players thought of the ‘patent box’
News
Market Highlights and 4 ASX Small Caps to watch on Wednesday
Health & Biotech
AdAlta soars after getting orphan drug designation for its shark-based drug
News
Market highlights and ASX small caps to watch on Wednesday
Health & Biotech
Megan Baldwin just joined the board of this ASX biotech stock
News
Trading Places: Alex Waislitz’s Thorney Opportunities chipped in to these ASX stocks
Health & Biotech
Dimerix to progress DMX-200 to phase 3 trial to treat kidney disease FSGS
Health & Biotech
ScoPo’s powerplays: It’s been ‘like a waterfall of information’ hitting us daily
News
ASX stocks in America: Opthea’s about to join the ranks but who’s there already?
News
Rise and Shine: What you need to know before the ASX opens
News